260 related articles for article (PubMed ID: 12529660)
1. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.
Broggini M; Marchini SV; Galliera E; Borsotti P; Taraboletti G; Erba E; Sironi M; Jimeno J; Faircloth GT; Giavazzi R; D'Incalci M
Leukemia; 2003 Jan; 17(1):52-9. PubMed ID: 12529660
[TBL] [Abstract][Full Text] [Related]
2. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
Gerber HP; Malik AK; Solar GP; Sherman D; Liang XH; Meng G; Hong K; Marsters JC; Ferrara N
Nature; 2002 Jun; 417(6892):954-8. PubMed ID: 12087404
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.
Masood R; Kundra A; Zhu S; Xia G; Scalia P; Smith DL; Gill PS
Int J Cancer; 2003 May; 104(5):603-10. PubMed ID: 12594815
[TBL] [Abstract][Full Text] [Related]
6. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
Avramis IA; Kwock R; Avramis VI
Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion.
Hayashibara T; Yamada Y; Miyanishi T; Mori H; Joh T; Maeda T; Mori N; Maita T; Kamihira S; Tomonaga M
Clin Cancer Res; 2001 Sep; 7(9):2719-26. PubMed ID: 11555584
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
9. Bilaterally increased VEGF-levels in muscles during experimental unilateral callus distraction.
Hansen-Algenstaedt N; Algenstaedt P; Böttcher A; Joscheck C; Schwarzloh B; Schaefer C; Müller I; Koike C; Rüther W; Fink B
J Orthop Res; 2003 Sep; 21(5):805-12. PubMed ID: 12919867
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
Erba E; Bassano L; Di Liberti G; Muradore I; Chiorino G; Ubezio P; Vignati S; Codegoni A; Desiderio MA; Faircloth G; Jimeno J; D'Incalci M
Br J Cancer; 2002 May; 86(9):1510-7. PubMed ID: 11986788
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
[TBL] [Abstract][Full Text] [Related]
12. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
[TBL] [Abstract][Full Text] [Related]
14. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
[TBL] [Abstract][Full Text] [Related]
15. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.
Zhang H; Wu J; Meng L; Shou CC
World J Gastroenterol; 2002 Dec; 8(6):994-8. PubMed ID: 12439912
[TBL] [Abstract][Full Text] [Related]
17. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells.
Kuramoto K; Uesaka T; Kimura A; Kobayashi M; Watanabe H; Katoh O
Cancer Res; 2000 Jan; 60(2):425-30. PubMed ID: 10667597
[TBL] [Abstract][Full Text] [Related]
18. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells.
Akiyama H; Tanaka T; Maeno T; Kanai H; Kimura Y; Kishi S; Kurabayashi M
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1367-74. PubMed ID: 11980848
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
Salven P; Hattori K; Heissig B; Rafii S
FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
